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Abstract. Heparin-binding epidermal growth factor- 
like growth factor (HB-EGF) is a member of the EGF 
family of growth factors, which interact with EGF re- 
ceptor to exert mitogenic activity. The membrane- 
anchored form of HB-EGF, proHB-EGF, is biologi- 
cally active, providing mitogenic stimulation to neigh- 
boring cells in a juxtacrine mode. ProHB-EGF forms a 
complex with diphtheria toxin receptor-associated pro- 
tein (DRAP27)/CD9, a tetra membrane-spanning pro- 
tein that upregulates the juxtacrine mitogenic activity 
of proHB-EGF. We explored whether other proteins 
associate with DRAP27/CD9 and proHB-EGF. Immu- 
noprecipitation with anti-DRAP27/CD9 resulted in 
preferential coprecipitation of integrin ot3~1 from Vero 
cell, A431 cell and MG63 cell lysates. Anti-integrin o~3 
or anti-integrin f31 coprecipitated DRAP27/CD9 from 
the same cell lysates. Chemical cross-linking confirmed 
the physical association of DRAP27/CD9 and integrin 
oL3131. Using Vero-H cells, which overexpress HB-EGF, 
we also demonstrated the association of proHB-EGF 
with DRAP27/CD9 and integrin a3131. Moreover, colo- 
calization of proHB-EGF, DRAP27/CD9, and integrin 
oL3f31 at cell-cell contact sites was observed by double- 
immunofluorescence staining. At cell-cell contact sites, 
DRAP27/CD9 was highly coincident with ot-catenin 
and vinculin, suggesting that DRAP27/CD9, proHB- 
EGF, and integrin a3f31 are colocalized with adherence 
junction-locating proteins. These results indicate that 
direct interaction of growth factors and cell adhesion 
molecules may control cell proliferation during the 
cell-cell adhesion process. 
C 
ELL-CELL interactions regulating cell growth and dif- 
ferentiation play a vital role in embryonic devel- 
opment,  morphogenesis  of  tissue,  and  mainte- 
nance of the adult organism (Whitman and Melton, 1989; 
Edelman and Crossin, 1991; Takeichi, 1991). These inter- 
actions are mainly mediated by two categories of proteins, 
growth factors and cell adhesion molecules. Growth fac- 
tors are generally secreted as diffusible proteins and trans- 
duce proliferation and differentiation signals by binding to 
specific receptors on the target cell membrane (Carpenter 
and Cohen, 1979), while cell adhesion molecules assemble 
animal cells into tissues by their adhesive properties and 
also regulate cell growth and differentiation by transduc- 
ing a signal  directly or via intracellular molecules associ- 
ated with their cytoplasmic domains (Geiger and Ayalon, 
1992; Juliano and Haskill, 1993). Thus, it has been postu- 
lated that proper expression and interaction of growth fac- 
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tors and cell adhesion molecules is essential for normal de- 
velopment  and  maintenance  of multicellular  organisms. 
However, direct interaction  between growth factors and 
cell adhesion molecules has not been demonstrated. 
Heparin-binding EGF-like growth factor (HB-EGF)  1 is 
a member of the EGF family (Higashiyama et al., 1991), 
which encompasses a number of structurally homologous 
mitogens  including  EGF,  TGF-o~, vaccinia virus  growth 
factor (Carpenter and Wahl, 1990), amphiregulin (Shoyab 
et al., 1989) and [3-cellulin (Shing et al., 1993). Like EGF, 
TGF-et,  and amphiregulin,  HB-EGF binds to and stimu- 
lates phosphorylation of the EGF receptor. Secreted ma- 
ture HB-EGF is a potent mitogen for NIH3T3 cells, bo- 
vine  aortic  smooth  muscle  cells,  rat  hepatocytes,  and 
human keratinocytes (Higashiyama et al., 1991). 
An important feature of HB-EGF is that it is a mem- 
1. Abbreviations  used in this paper.  DRAP27, diphtheria toxin receptor- 
associated protein; DSP, Dithiobis(succinimidylpropionate);  DT, diphthe- 
ria  toxin; HB-EGF,  heparin-binding EGF-like  growth  factor; proHB- 
EGF, membrane-anchored form of HB-EGF. 
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sequence of human HB-EGF cDNA predicts a precursor 
protein of 208  amino acids composed of signal peptide, 
heparin-binding, EGF-like, transmembrane, and cytoplas- 
mic  domains  (Higashiyama et  al.,  1991).  Although the 
membrane-anchored form of HB-EGF (proHB-EGF) can 
be  cleaved to yield a  mature biologically active protein 
containing 75-86  amino acids, a  considerable amount of 
proHB-EGF remains uncleaved on the cell surface. We 
have shown that proHB-EGF transduces biological signals 
in a  nondiffusible manner to neighboring cells (Higash- 
iyama et al., 1995). Such "juxtacrine stimulation" has been 
demonstrated for other membrane-anchored growth fac- 
tors and lymphokines, including TGF-a (Brachmann et al., 
1989; Wong et al., 1989), tumor necrosis factor a  (Perez et 
al., 1990), colony-stimulating factor 1 (Stein et al., 1990), 
and c-kit ligand (Flanagan et al., 1991). 
ProHB-EGF is not only a membrane-anchored growth 
factor or a  precursor for soluble growth factor, but also 
acts as the specific receptor for diphtheria toxin (DT) and 
mediates  endocytosis of the  receptor-bound  toxin  (Na- 
glich et al., 1992; Iwamoto et al., 1994). Studies of the DT 
receptor revealed that proHB-EGF forms a complex with 
another membrane protein known as DRAP27, a 27-kD 
DT receptor-associated protein in Vero cells, a monkey 
kidney cell line (Iwamoto et al., 1991, 1994). DRAP27 is 
identical to human CD9  (Mitamura et al.,  1992),  which 
was first identified as a cell surface antigen on lymphohe- 
mopoietic cells (Kersey et al., 1981). Anti-DRAP27 anti- 
bodies inhibit the binding of DT to proHB-EGF (Iwamoto 
et al., 1991) and coprecipitate proHB-EGF with DRAP27/ 
CD9 (Iwamoto et al., 1994), indicating that these two pro- 
teins are closely associated in the cell membrane. Further- 
more,  coexpression  of DRAP27/CD9  with proHB-EGF 
markedly upregulates juxtacrine growth stimulation activ- 
ity of proHB-EGF (Higashiyama et al., 1995)  as well as 
DT binding and DT sensitivity of cells (Mitamura et al., 
1992; Iwamoto et al., 1994). 
The number of DRAP27/CD9 molecules on the surface 
of Vero ceils is at least 100-fold higher than the number of 
proHB-EGF molecules (Iwamoto et al., 1991). This sug- 
gests that a large fraction of DRAP27/CD9 may not be as- 
sociated with proHB-EGF and that DRAP27/CD9 could 
have other functions. Recent studies by other groups im- 
ply that DRAP27/CD9 may function in the cell adhesion 
process  (Letarte  et  al.,  1993; Masellis-Smith and  Shaw, 
1994)  and cell motility (Ikeyama et al.,  1993). Moreover, 
DRAP27/CD9 belongs to the newly identified tetramem- 
brane-spanning protein family, of which several members 
may be involved in the cell adhesion system (Bell et al., 
1992; Imai and Yoshie, 1993). These results prompted us 
to examine whether DRAP27/CD9, and proHB-EGF as- 
sociate with cell adhesion molecules. 
In this article, we provide evidence that DRAP27/CD9 
and  proHB-EGF  associate  with integrin oL3131. Integrin 
a3[~l  differs from typical focal contact integrins  and is 
found in cell-cell adhesion sites  (Carter  et al.,  1990)  as 
well as in cell-substrate adhesion sites. We observed by 
double  immunofluorescence staining  that  proHB-EGF, 
DRAP27/CD9 and integrin et3[~l are colocalized at cell- 
cell contact sites. Together with the results of coprecipita- 
tion and  chemical cross-linking experiments, these  data 
show a direct link of the membrane-anchored growth fac- 
tor and cell adhesion molecules at cell--cell contact sites. 
Materials and Methods 
Cells and Cell Cultures 
Vero cells from monkey kidney were maintained in MEM with nonessen- 
tial amino acids (MEM-NEAA) supplemented with heat-inactivated 10% 
calf serum. Vero-H ceils were isolated by transfection with human HB- 
EGF cDNA into Vero cells (Goishi, K., S. Higashiyama, M. Klagsbrun, N. 
Nakano, T. Umata, M. Ishikawa, E. Mekada, and N. Taniguchi, manu- 
script in preparation). Human adenocarcinoma A431 ceils and human os- 
teosarcoma MG63 cells were cultured in DMEM supplemented with 10% 
FCS and MEM-NEAA with 10% FCS, respectively. 
Proteins and Antibodies 
DT and CRM1O7 were produced as described previously (Uchida et al., 
1973), and anti-DT antiserum was raised by immunizing rabbits with for- 
malin-fixed diphtheria toxoid. The antiserum was purified by ammonium 
sulfate precipitation and affinity chromatography with immobilized DT. 
Anti-DRAP27/CD9 mAb 007 (IgG2a) was prepared and purified as pre- 
viously described (Iwamoto et al.,  1991).  Other anti-CD9 mAbs, TP82 
(IgG1), ALB6 (IgG1), and BU16 (IgG2a), were obtained from Nichirei 
Co., Ltd. (Tokyo, Japan), MBL Co., Ltd. (Nagoya, Japan), and The Bind- 
ing Site Inc. (Birmingham, England), respectively. 
Rabbit anti-HB-EGF antisera H6 and M6 were obtained as described 
previously (Iwamoto, et al., 1994; Higashiyama et al., 1995). Mouse anti- 
integrin 131 mAbs 4B4 (IgG1, Morimoto et al., 1985)  and K20 (IgG2a, 
Amiot et al., 1986) were purchased from Coulter Immunology (Hialeah, 
FL) and MBL Co., Ltd., respectively. Rabbit anti-a3 and anti-131 antisera 
were from Chemicon International, Inc. (Temecula, CA). Mouse mAbs to 
integrin et2 (P1E6), a3 (PIB5), a5 (P1D6)  (Wayner et al., 1988) and av 
(VNR147; Freed et al., 1989) were purchased from Telios Pharmaceuti- 
cals, Inc. (San Diego, CA). 
Mouse anti-vinculin IgG was purchased from Chemicon International, 
Inc.  and mouse anti-EGF receptor from Genzyme Corp.  (Cambridge, 
MA). Rat anti-c~ catenin was a generous gift from Dr. Shoichiro Tsukita 
(Kyoto University, Kyoto, Japan). 
Cell Surface Labeling and Chemical Cross-Linking 
Cell surface iodination was carried out by the lactoperoxidase method. 
Cells were grown in  100-mm  dishes and  washed with Hepes-buffered 
HBSS three times. Then cells were radiolabeled with 0.5 mCi Na125I (Am- 
ersham  International,  Amersham, UK), 0.2  U  lactoperoxidase (Sigma 
Chemical Co., St. Louis, MO), and 20 ixl of 1:20,000-diluted  30% hydro- 
gen peroxide in 625 ixl of HBSS for 5 min. The reaction was stopped by 
addition of excess tyrosine and 500 nM Dq'T, and cells were washed with 
HBSS. 
Cell surface biotinylation was carried out as follows. Ceils were washed 
with HBSS and incubated in a solution containing 150 mM NaC1, I0 mM 
Hepes, 0.2  ixg/ml NHS-LC-Biotin (Pierce Chemical Co., Rockford, IL), 
0.2 mM CaC12 and MgC12, pH 8.0, for 30 min at 4°C. The reaction was 
stopped by the addition of 40 mM glycine, and cells were washed with 
HBSS. 
Chemical cross-linking was carried, out as described previously (Iwa- 
moto et al., 1994) with minor modifications. Briefly, the cells were washed 
with  PBS  (137  mM  NaC1,  0.67  mM  KC1,  8  mM  Na2HPO4,  1.4  mM 
KH2PO4)  and incubated for 30 rain at 4°C with 0.8 mM Dithiobis(succin- 
imidylpropionate) (DSP; Pierce Chemical Co.), or 1% DMSO for control, 
in 20 mM sodium bicarbonate buffer, 150 mM NaCI, 0.2 mM CaCI2, 0.2 
mM MgCI2, pH 8.5.  DSP is cleavable under reducing conditions. Cells 
were washed twice with TBS (20 mM Tri-HCl, 100 mM NaC1, pH 7.5), 
once with PBS, and used for further studies. 
Immunoprecipitation and SDS-PA  GE 
Cells were lysed with HBS (10 mM Hepes, 150 mM NaC1, pH 7.0) con- 
taining 10 mM CHAPS, 10 txg/ml chymostatin, and 20 i~g/ml antipain, un- 
less otherwise mentioned, and kept for 30 min at 4°C. The lysates were 
cleared of insoluble material by centrifugation at 40,000 g for 30 min, and 
the supernatant was precipitated with primary antibodies at a concentra- 
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ond antibodies (Cappel  Laboratories, Durham, NC).  Protein A-Seph- 
arose 4B (Pharmacia LKB Biotechnology, Tokyo, Japan) was also used 
for some experiments. The gel was washed with washing buffer (HBS con- 
taining 10 mM CHAPS) and then boiled with SDS-PAGE sample buffer. 
Material recovered from the gel  was  analyzed by SDS-PAGE with or 
without 50 mM DTT. Unless otherwise indicated, gradient gels from 4 to 
20% acrylamide (Daiichi Pure Chemicals Co., Ltd.,  Tokyo, Japan) were 
used for SDS-PAGE. For the iodinated samples, gels were dried, exposed 
to imaging film, and analyzed using an image analyzer (model BAS2000; 
Fujix, Tokyo, Japan). 
In the reprecipitation experiment, ~25I-labeled  lysates were precipitated 
with Sepharose 4B-conjugated anti-DRAP27/CD9 mAb 007. After the 
gel was washed with washing buffer, it was treated with elution buffer (10 
mM Hepes,  500 mM NaCl,  10 mM CHAPS,  1% Triton X-100,  0.02% 
SDS) for 1 h at 4°C. The eluted material was immunoprecipitated again 
with the indicated antiintegrin mAb and Sepharose 4B-conjugated goat 
anti-mouse IgG in the presence of the detergents mentioned above. Pre- 
cipitated material was subjected to SDS-PAGE. 
Western Blotting 
Samples subjected to SDS-PAGE were electrotransferred to an Immo- 
bilon membrane. The membrane was blocked with TBS containing 3% 
skim milk at room temperature for 1 h, then incubated at 4°C overnight 
with antiintegrin a3 mAb (100 ng/ml) or anti-HB-EGF antiserum H6 (1: 
20,000 dilution) in TBS containing 1% skim milk and 200 mM NaC1. After 
thorough washing with TYBS  (TBS containing 0.05%  Tween 20),  the 
membranes were incubated with HRP-conjugated donkey anti-rabbit IgG 
(Chemicon International, Inc.) at a concentration of 400 ng/ml, washed 
with TTBS, and analyzed with an ECL-Western blotting kit (Amersham 
International). For biotinylated samples, the membrane was blocked with 
3% BSA in TBS, and proteins were detected by incubation with 100 ng/ml 
HRP-streptavidin (Pierce Chemical Co.). 
Indirect Immunofluorescence Microscopy 
Cells grown on coverglasses  were fixed with 3.7%  paraformaldehyde in 
HBSS for 30 min at 4°C and permeabilized with 0.1% Triton X-100 at 4°C 
for  2  min if needed.  Then  cells  were  blocked  with blocking solution 
(HBSS containing 10% skim milk) at room temperature for 30 min and in- 
cubated with primary antibodies (5 I~g/ml, or a dilution of 1:100) in block- 
ing solution. After washing,  cells were treated with a fluorescent second 
antibody or biotinylated second antibody followed by streptavidin-Cy3 
(Pierce Chemical Co.). The samples were mounted in HBSS containing 1 
}xg/ml p-phenylenediamine and  observed under  a  fluorescence micro- 
scope (Nikon MICROPHOT-FXA, Nikon Co. Ltd., Tokyo, Japan) or la- 
ser  scanning  confocal  microscope  (Carl  Zeiss  LSM  10,  Carl  Zeiss, 
Oberkochen, Germany). Confocal images were obtained and analyzed us- 
ing an LSM 10 microscope equipped with analysis  software.  For double 
staining using mouse mAbs, subclass  specific anti-mouse IgG antibodies 
(Southern Biotechnology Associates, Inc., Birmingham, AL) were used as 
second antibodies at 1:100 dilution. 
For indirect staining of proHB-EGF with DT, Vero and Vero-H cells 
Figure 1.  Anti-DRAP27/CD9 antibodies coprecipitate integrin ct3131. (A) Immunoprecipitated material analyzed by SDS-PAGE under 
nonreducing conditions. 125I-labeled Vero cells were lysed with 10 mM CHAPS solution, and lysates were immunoprecipitated with var- 
ious antibodies: irrelevant antibody (lane 1), anti-CD9 mAb 007 (lane 2), ALB6 (lane 3), TP82 (lane 4), BU16 (lane 5), or a mixture of 
anti-integrin a3 and anti-integrin ct5 mAbs (lane 6). Lane 7 contained total cell lysate. Gels were analyzed with a BAS2000 image ana- 
lyzer. Bars on the right margin show molecular mass markers in kilodaltons. Scans of the signal intensity of lanes 2 and 7 are shown to 
the left.  (B) Immunoprecipitated material analyzed by SDS-PAGE  under reducing conditions. Antibodies used: irrelevant antibody 
(lane 1), anti-CD9 mAb 007 (lane 2), mixture of anti-integrin a3 and ~5 mAbs (lane 3). Lane 4 contained total cell lysate. (C) Reprecip- 
itation of coprecipitated material. 125I-labeled Vero cell lysates were immunoprecipitated with Sepharose 4B-conjugated anti-DRAP27/ 
CD9 mAb. Precipitated materials were eluted from the gels as described in Materials and Methods, and each aliquot was immunopre- 
cipitated again with irrelevant mAb (lane 1), anti-a2 (lane 2), anti-et3 (lane 3), anti-et5 (lane 4), anti-ctv (lane 5), anti-131 (lane 6), or anti- 
CD9 mAb (lane 7). Precipitated material was analyzed by SDS-PAGE under nonreducing condition. 
Nakamura et al. Association of  HB-EGF, DRAP27/CD9 and Integrin  1693 were incubated for 4 h on ice with 100 ng/ml DT in Hepes-buffered MEM- 
NEAA supplemented with 10% calf serum. Cells were washed and then 
incubated with rabbit anti-DT (1:100  dilution) for 1 h  at 4°C and fixed 
with 3.7%  paraformaldehyde for 1 h  on ice. Then cells were incubated 
with biotinylated goat anti-rabbit IgG (Zymed Laboratories Inc., South 
San Francisco, CA), followed by streptavidin-Cy3. In the double-staining 
experiment, DT-treated Vero-H cells were incubated with rabbit anti-DT 
antibody and mouse anti-integrin a3 for 1 h  on ice and fixed. Then cells 
were incubated with FITC-labeled goat anti-mouse IgG (Chemicon Inter- 
national, Inc.) and biotinylated goat anti-rabbit IgG followed by strepta- 
vidin-Cy3 and observed under a fluorescence microscope. 
Results 
Association of  DRAP271CD9 with Integrin a3fll 
To identify proteins that associate with DRAP27/CD9, Vero 
cell lysate was immunoprecipitated with anti-DRAP27/CD9 
antibody, and  polypeptides coprecipitated with DRAP27/ 
CD9 were analyzed. Surface-iodinated Vero cells were lysed 
with 10 mM CHAPS solution, and the lysate was immuno- 
precipitated with anti-DRAP27/CD9 mAb, followed by incu- 
bation with immobilized goat anti-mouse IgG. The precipi- 
tated material was analyzed by SDS-PAGE under reducing 
or nonreducing conditions. Anti-DRAP27/CD9 mAb (clone 
007) precipitated 150- and  115-kD  proteins in addition to 
DRAP27 itself (27 kD) under nonreducing conditions (Fig. 1 
A, lane 2). Under reducing conditions, the 150- and 115-kD 
bands were both shifted to N135 kD (Fig. 1 B, lane 2). Con- 
trol antibody did not precipitate any polypeptides (Fig. 1, A 
and B, lanes 1). The 150- and 115-kD polypeptides were ma- 
jor polypeptides of surface-iodinated Vero cells  (Fig.  1 A, 
lane 7, and Fig.  1 B, lane 4), so it was possible that these 
polypeptides might be nonspecific contaminants. However, 
this was not the  case,  because  radiograms of the electro- 
phoresed gels indicated that 150- and ll5-kD  bands were 
specifically concentrated by precipitation with anti-CD9 anti- 
body (Fig. 1 A, radiogram). Precipitation of 150- and ll5-kD 
polypeptides was also observed with other independently iso- 
lated anti-human CD9 mAbs (ALB6, TP82, BU16)  (Fig. 1 
A, lanes 3-5), which rules out precipitation of the 150- and 
ll5-kD polypeptides due to an irrelevant cross-reaction of 
mAb 007. 
The mobilities of the coprecipitated proteins in SDS gel 
and the shifts of these proteins in reducing conditions are 
quite similar to those of some [31-containing integrins (Fig. 
1 A, lane 6, and Fig. 1 B, lane 3). To examine whether the 
polypeptides were integrins, material recovered from anti- 
CD9/DRAP27  precipitates  was  precipitated  again  with 
mAbs specific for each integrin subunit, and the precipi- 
tated material was  subjected to  SDS-PAGE  (Fig.  1  C). 
Only mAb directed to integrin a3 or [31 precipitated the 
150- and 115-kD polypeptides (Fig. 1 C, lanes 3 and 6). As 
shown in Fig. 2 A, Vero cells also express a2, a5, and txv 
subunits, but these integrin ~x subunits were not included 
in the material precipitated with anti-DRAP27/CD9 anti- 
body. Western blotting analysis confirmed that the 150-kD 
band is integrin et3 (see Fig. 4 C, lane 4) and the ll5-kD 
band is integrin [31 (data not shown). 
Next, in a  reciprocal experiment, Vero cell lysate was 
immunoprecipitated with  each  of the  anti-integrin  sub- 
unit-specific antibodies. As shown in Fig. 2 A, anti-ix3 an- 
tibodies precipitated  150- and  ll5-kD  bands  of integrin 
and also coprecipitated a 27-kD polypeptide. Anti-J31 anti- 
bodies also precipitated the 27-kD polypeptide in addition 
to 180- and 150-kD integrin et subunits and the ll5-kD [31 
Figure 2.  Coprecipitation of DRAP27/CD9 and ct3131 in Vero, A431, and MG63 cells. 125I-labeled cell lysates of Vero cells (A), A431 
cells (B), and MG63 cells (C) were immunoprecipitated with irrelevant mAb (lanes 1), anti-et2 (lanes 2), anti-oL3  (lanes 3), anti-a5 (lanes 
4), anti-ctv (lanes 5), anti-[31 (lanes 6), or anti-CD9 (lanes 7) and Sepharose 4B--conjugated  anti-mouse IgG. Precipitated material was 
analyzed by SDS-PAGE under nonreducing condition. 
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firmed that the 27-kD polypeptide is DRAP27/CD9 (data 
not  shown).  Immunoprecipitation with  anti-integrin  a2, 
a5, or etv antibodies indicated that Vero cells contain these 
integrins,  but  coprecipitation of DRAP27/CD9  was  not 
observed  (Fig.  2  A).  Coprecipitation  of  DRAP27/CD9 
with anti-or3  antibody or 131  antibody was  also observed 
when  different  antibodies  directed  against  et3  (llG5, 
M-Kid)  or  131  (DF5,  K20,  P4C10)  were  used  (data  not 
shown). 
There is no reason to expect immunological cross reac- 
tivity between integrin et3 or 131 and DRAP27/CD9, as in- 
tegrin  OL3  and  131  have  no  sequence  homology  with 
DRAP27/CD9. In fact, almost no coprecipitation was ob- 
served when cells were lysed with Triton X-100 (data not 
shown). Thus, coprecipitation of DRAP27/CD9 and inte- 
grin  et3131 indicates  physical  association  of these  mole- 
cules. 
To exclude the possibility of artifactual association after 
cell lysis, we carded out cross-linking studies of DRAP27/ 
CD9 and integrin molecules. When Vero cells were lysed 
with a buffer containing 500 mM NaC1, 1% Triton X-100, 
and 0.02% SDS, anti-DRAP27/CD9 mAb 007 precipitated 
DRAP27/CD9 (Fig. 3, arrow) but not integrin et3131, due 
to the dissociation of the proteins under these conditions 
(Fig. 3, lane 2). However, integrin a3 and 131 subunits are 
noncovalently linked in this condition (see Fig. 1 C). When 
cells were treated with the cleavable bifunctional cross- 
linker DSP before cell lysis, high molecular mass  bands 
were  observed in  addition  to  the  27-kD  DRAP27/CD9 
band  after  SDS-PAGE  under  nonreducing  conditions 
(Fig. 3, lane 5). Under reducing conditions, the high mo- 
lecular mass bands shifted to 135 kD (Fig. 3, lane 6, arrow- 
head), the mobility of integrin a3 subunit and [31 subunits 
(Fig. 3, lane 3). These results indicate that coprecipitation 
of DRAP27/CD9 and integrin does not result from incom- 
plete solubilization or from aggregation of the molecules 
after cell lysis. We conclude that DRAP27/CD9 and inte- 
grin  et3131 are  physically  associated  in  Vero  cell  mem- 
brane. 
To examine whether association of DRAP27/CD9  and 
integrin et3lM is generally seen, we carded out coprecipita- 
tion experiments using other cell lines. A431 cells, a cell line 
derived  from  human  adenocarcinoma,  express  predomi- 
nantly integrins or2, or3, and ~1, and also small amounts of 
~5 and otv subunits (Fig. 2 B). Anti-DRAP27/CD9 mAb co- 
precipitated 150-  and 115-kD protein bands  as well as an 
unidentified 180-kD band (Fig. 2 B, lane 7). Reprecipitation 
experiments showed that these 150- and 115-kD bands were 
et3 and 131 subunits.  Reciprocally, 27-kD polypeptide was 
coprecipitated when anti-integrin a3 or [$1 was used (Fig. 2 
B, lanes 3 and 6), but not with anti-et2, -OL5  or -otv (Fig. 2 B, 
lanes 2, 4, and 5). These results indicate that DRAP27/CD9 
associates with integrin et3131 in A431 cells. Coprecipitation 
of ot3131 but not ot2131 with anti-DRAP27/CD9, despite ex- 
pression of similar amounts of these integrins by A431 cells, 
provides further evidence that coprecipitation of et3131 with 
DRAP27/CD9 is due to specific association of these pro- 
teins. MG63 cells, a human osteosarcoma cell line, express 
integrin OL2, Or3, aS, OtV, and 131 (Fig. 2 C). In these cells, ex- 
pression of integrin a2 and or5 is higher than expression of 
or3. The 150-  and 115-kD bands again coprecipitated with 
Figure 3.  Cross-linking of DRAP27/CD9  and integrin et31M. Ra- 
dioiodinated  Vero ceils were treated with the homobifunctional 
cleavable cross-linking reagent DSP (lanes 4-6) or control solu- 
tion (lanes 1-3). Then cells were labeled with 125INa, lysed with 
solution containing  1% Triton X-100, and the lysate was immu- 
noprecipitated  with  irrelevant  mAb  (lanes  I  and 4),  anti-CD9 
mAb 007 (lanes 2, 5, and 6) or rabbit anti-131 (lane 3). Precipi- 
tated materials were analyzed by SDS-PAGE under nonreducing 
(lane 5) or reducing conditions (lanes 1-4, 6). 
DRAP27/CD9 using anti-DRAP27/CD9 antibody (Fig. 2 C, 
lane 7), and 27-kD polypeptide coprecipitated with integrin 
a3 or 131 mAb (Fig. 2 C, lanes 3 and 6). Reprecipitation ex- 
periments confirmed that the 150- and 115-kD bands were 
integrin et3 and 131, respectively (data not shown). Thus, as- 
sociation of DRAP27/CD9 and integrin ot3131 was observed 
in all three cell lines tested. Trace amounts of et2 and or5 in- 
tegrin were detected in the reprecipitation experiment with 
the  material  precipitated  with  anti-DRAP27/CD9  mAb 
from MG63 cell lysate; thus, ot2131 and et5131 may also asso- 
ciate with DRAP27/CD9 in this cell line to a lesser degree. 
Association of  Integrin a3flI with 
proHB-EGF-DRAP27/CD9 Complex 
We have recently demonstrated that DRAP27/CD9 forms 
a complex with DTR/HB-EGF precursor (Iwamoto et al., 
1994). Therefore, we examined whether integrin et3131 is 
associated  with  only  DRAP27/CD9,  or  also  with  the 
proHB-EGF-DRAP27/CD9 complex. Because it is  diffi- 
cult  to  demonstrate  coprecipitation of proHB-EGF and 
DRAP27/CD9  from  Vero  cell  lysate  due  to  the  large 
difference  in  the  abundance  of  DRAP27/CD9  and 
proHB-EGF, we used cell lysates of Vero-H cells, stable 
transformants  of Vero cells  expressing ~20  times  more 
proHB-EGF on the  cell surface  (Goishi, K.,  S.  Higash- 
iyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa, 
Nakamura et al. Association  of  HB-EGF, DRAP27/CD9 and lntegrin  1695 Figure 4.  Coprecipitation of proHB-EGF, DRAP27/CD9 and integrin  et3131. (A) Biotinylated  Vero-H cells were lysed with 10 mM 
CHAPS solution.  Lysates were immunoprecipitated with irrelevant mouse IgG (lane 1), rabbit anti-HB-EGF antibody M6 (lane 2), 
anti-DRAP27/CD9  mAb 007 (lane 3), or anti-131 K20 antibody (lane 4) followed by protein A-Sepharose 4B. Precipitated materials 
and the total cell lysate (lane 5) were subjected  to SDS-PAGE and Western blotting. Protein bands were detected with streptavidin- 
HRP. Bars on the right margin represent the molecular mass markers in kilodaltons.  (B) Vero-H cell lysate was immunoprecipitated 
with irrelevant mAb (lane 1), anti-HB-EGF M6 (lane 2), anti-CD9 BU16 (lane 3), or anti-f31 K20 antibody (lane 4). Precipitated mate- 
rial and total cell lysate (lane 5) were subjected to SDS-PAGE (15% gel), and polypeptides were transferred to a membrane. The mem- 
brane was probed with rabbit anti-HB-EGF antiserum H6 and HRP-conjugated donkey anti-rabbit IgG. (C) Vero-H cell lysate was 
precipitated with (lane 2) or without DT (lane 1), followed by Sepharose 4B-conjugated anti-DT mAb. The same cell lysate was immu- 
noprecipitated with irrelevant mouse antibody (lane 3), mouse anti-CD9 mAb BU16 (lane 4), or mouse anti-ct3 mAb (lane 5) followed 
by anti-mouse IgG-Sepharose 4B. Precipitated material and total lysate (lane 6) were subjected to SDS-PAGE, Western blotting, and 
probed with rabbit anti-or3 antibody and HRP-conjugated donkey anti-rabbit IgG. 
E. Mekada, and N. Taniguchi, manuscript in preparation). 
Since  HB-EGF is  much more  efficiently labeled  by the 
biotinylation method than by iodination, lysate from sur- 
face-biotinylated Vero-H cells was precipitated with anti- 
HB-EGF antibody, anti-DRAP27/CD9 mAb, or anti-inte- 
grin 131 mAb, and protein A-Sepharose 4B. 
Immunoprecipitates were analyzed by SDS-PAGE and 
Western blotting.  When cell lysate was precipitated with 
anti-DRAP27/CD9  mAb,  several bands  of 150,  115,  50, 
27, and 27-20 kD were observed (Fig. 4 A, lane 3). The 27- 
kD band was confirmed as DRAP27/CD9 itself by West- 
ern blotting (data not shown). The 150- and 115-kD bands 
were integrin et3131, and the bands ranging from 20 to 27 
kD were proHB-EGF. The 50-kD band has not been iden- 
tified.  When  cell  lysate  was  precipitated  with  anti-HB- 
EGF antibody, the  150- and  115-kD integrin bands were 
also coprecipitated in addition to DRAP27/CD9  (27 kD) 
and proHB-EGF itself (Fig. 4 A, lane 2). Immunoblotting 
confirmed that the  115-kD band is 131  (data not shown). 
Conversely, when  cell  lysate was precipitated  with  anti- 
integrin 131 antibody, 180-, 150-, 115-, 50-, 27-, and 20-27-kD 
bands were observed (Fig. 4 A, lane 4). The 180-, 150-, and 
115-kD bands were confirmed to be integrin a  and [3 sub- 
units, and the faint but significant 20-27-kD bands proHB- 
EGF  by immunoblotting  (Fig.  4  B).  As  proHB-EGF is 
known to serve as a receptor for DT, we performed immu- 
noprecipitation of Vero-H cell lysate with DT and immo- 
bilized  anti-DT  antibodies  and  Western  blotting  studies 
with anti-HB-EGF and  anti-integrin ~3. As a  result,  DT 
precipitated a 150-kD band of integrin or3 (Fig. 4 C, lane 2) 
as  well  as  20-27-kD  bands  of  proHB-EGF  (data  not 
shown), while no bands are observed in the absence of DT 
(Fig. 4, lane 1). These results indicate that at least some of 
the integrin a3131 is in a complex with proHB-EGF, possi- 
bly mediated by association with DRAP27/CD9. 
Colocalization of  DRAP27/CD9 with Integrin 
a3fll at Cell-Cell Contact Sites 
We next examined where in the cell integrin 0t3131 associ- 
ates with DRAP27/CD9 and proHB-EGF. First, localiza- 
tion of DRAP27/CD9 and integrins in Vero cells was ana- 
lyzed by indirect immunofluorescence staining. Fig. 5 shows 
a  typical  immunofluorescence  pattern  from  Vero  cells 
stained with anti-DRAP27/CD9 antibody or one of the an- 
tibodies to the integrin subunit a2, a3, orS, av, or 131 from a 
conventional  fluorescence  microscope.  Anti-DRAP27/ 
CD9  produced  intense  staining  at  cell-ceU  boundaries 
(Fig. 5 A). Weak punctate fluorescence was also observed 
at the apical area. With sparsely grown cells, fine needle- 
like  processes  attaching  neighboring  cells  were  stained 
with anti-DRAP27/CD9  (see Fig. 6 A). These needlelike 
processes at cell-cell contact sites were especially promi- 
nent  when  nonfixed  cells  were  stained  (Fig.  5  G). 
The Journal of Cell Biology,  Volume 129, 1995  1696 Figure 5.  Localization  of DRAP27/CD9 and integrins. Vero cells were fixed, stained with anti-CD9 BU16 (A), anti-~x3 (B), anti-et2 (C), 
anti-et5 (D), anti-av (E), or anti-IM 4B4 antibody (F), and observed under a fluorescence  microscope. Exposure times for photographs 
were adjusted  depending on the intensity  of fluorescence.  G and H show patterns from staining of nonfixed cells in semiconfluent  cul- 
ture with anti-DRAP27/CD9 and anti-et3 antibodies,  respectively. Bar, 50 i~m. 
DRAP27/CD9  was  also  observed at  cell surfaces not  in 
contact  with  other  cells  and  especially at  microvilli-like 
structures projecting from the cell surface (see Fig.  6 A, 
arrows). 
Integrin ~x3 was also localized at cell-cell boundaries of 
Vero cells (Fig. 5, B and H), consistent with previous studies 
for other types of cells (Larjava et al., 1990; Symington et 
al.,  1993).  The  staining  pattern  is  quite  similar to that  of 
DRAP27/CD9.  Integrin et3  was also  observed in  the  mi- 
crovilli-like structures. The only difference in staining pat- 
terns of DRAP27/CD9 and integrin et3 was integrin et3 was 
not observed at free surfaces (see Fig. 6 D). Integfin et2, ct5, 
and ~xv were observed mainly at the basement membrane 
and could be scarcely detected at cell--cell boundaries on ac- 
count of their weak fluorescence (Fig. 5, C-E). Weak fluo- 
rescence  was  observed  at  the  basement  membrane  after 
staining for DRAP27/CD9, but the pattern was quite differ- 
ent from those of integrin et2, et5, and av. Integrin 131 forms 
heterodimers with a2, a3, or a5, and in fact this integrin was 
observed both at cell-cell boundaries and at the basement 
membrane (Fig. 5 F). 
Observation  with  a  confocal  laser  microscope  showed 
that it is ~10 ~m from the basement membrane to the api- 
cal tip of Vero cells.  We obtained sectioned images of the 
same field by changing the focus from the basement mem- 
brane to apical tip at 1.2 ~m intervals. Fig. 6 displays opti- 
cally sectioned images of Vero cells. When the focus was 
adjusted at basement membrane (z = 1), DRAP27/CD9 was 
observed mainly at the cell-cell boundary and free surfaces 
(Fig. 6 A). Where one cell appears to overlap another cell, 
DRAP27/CD9  is present in planar cell processes. At this 
height, tx3 is also localized at cell-cell boundaries with a pat- 
tern similar to DRAP27/CD9,  except that there is little or 
no staining at free surfaces (Fig. 6 D). When the focus was 
adjusted to 1.2 (z = 2) or 2.4 (z = 3) I~m above the basement 
membrane, both DRAP27/CD9 (Fig. 6, B and C) and inte- 
grin et3 (Fig. 6, E  and F) were observed in continuous lines 
at cell-cell boundaries.  Similar patterns at positions z  =  1 
through z = 3 were seen in cells stained with anti-integrin 131 
(data not shown). In contrast to integrin et3 and DRAP27/ 
CD9, integrin etv is observed almost exclusively in arrow- 
head-like structures at the level of the basement membrane 
(z = 1) (Fig. 6, G-/). 
The staining patterns for DRAP27/CD9 and integrin et3 in- 
dicate that these molecules colocalize at cell--cell boundaries. 
To  verify the  colocalization,  double  staining  of DRAP27/ 
CD9 and integrin m3 was performed. Fig. 7, G-J shows the 
specificity of the  double staining.  When  anti-a3 mAb was 
omitted in  the  double  staining  procedure,  only DRAP27/ 
CD9  (red)  was observed, while  when anti-CD9  mAb was 
omitted, only integrin or3 protein (green) was observed. Fig. 
7, A  and B, show DRAP27/CD9  and tx3 at a  lower height 
(between z = 1 and z = 2). Superposition of the two images 
(Fig. 7 C) shows that the broader areas of staining of cell pro- 
cesses  are  well  overlapped  (arrowheads).  The  cell-cell 
boundary seen at position z = 3 also largely overlapped (Fig. 
Nakamura et al. Association of  HB-EGF, DRAP27/CD9 and lntegrin  1697 Figure 6.  Confocal images of cells stained for DRAP27/CD9,  integrin a3 and av. Vero cells were fixed and stained with anti-CD9 mAb 
BU16 (A-C), anti-ct3 mAb (D-F), or anti-ctv mAb (G-/) and observed with a confocal laser microscope. The same field of cells was ob- 
served from basement membrane to apical tip by adjusting different foci: basement membrane (A, D, and G); 1.2 ~m above basement 
membrane (B, E, and H); or 2.4 Ixm above basement membrane (C, F, and/). Arrows show microvilli-like structures projecting  from 
cell surface. Bars, 100 Ixm. 
7, D-F). These results indicate that DRAP27/CD9 colocal- 
izes with integrin ct3JM at cell--ceU contact sites. 
Colocalization of  proHB-EGF and Integrin a3131 
Localization of proHB-EGF was also analyzed by immu- 
nofluorescence. Fig. 8 A  shows the distribution of proHB- 
EGF  in  Vero  cells  stained  with  anti-HB-EGF  antibody 
H6. Although the fluorescence was very faint, specific flu- 
orescence of proHB-EGF was observed mainly at cell--cell 
boundaries as expected. Under similar staining conditions, 
however, Vero-H cells showed intense, punctate fluores- 
cence all around the cell surface in addition to intense flu- 
orescence at ceU-cell contact sites (Fig. 8 C). Observation 
with  a  confocal microscope showed that proHB-EGF in 
Vero-H cells is present from the basement membrane to 
the apical tip (data not shown). This broad distribution of 
proHB-EGF may be due to the overexpression of the pro- 
tein. 
We  also  examined the  distribution  of proHB-EGF by 
staining  with DT and  anti-DT antibody.  A  recent  study 
shows that DT binds to the EGF domain of HB-EGF but 
does not bind to other EGF family growth factors (Mita- 
mura et al., 1995). Furthermore, a series of experiments on 
the  interaction  of proHB-EGF  and  DRAP27/CD9  sug- 
gested that DT preferentially binds to the proHB-EGF- 
DRAP27/CD9 complex (Iwamoto et al., 1991,  1994; Mita- 
mura et al., 1992). Fig. 8 B  shows that the staining pattern 
with DT is almost identical to that seen with anti-HB-EGF 
antibody,  indicating  localization  of  the  proHB-EGF- 
DRAP27/CD9  complex  at  cell-cell  boundaries.  When 
CRM107, a mutant protein of DT without receptor-binding 
activity, was used as a control for nonspecific staining, no 
fluorescence was observed (data  not  shown).  Compared 
with  anti-HB-EGF,  DT  stained  Vero-H  cells  preferen- 
tially at cell-cell contact sites (Fig. 8 D). These results indi- 
cate  that  the  distribution  of the  proHB-EGF-DRAP27/ 
CD9 complex in Vero-H cells is more restricted than that 
of proHB-EGF itself in these cells. To examine where the 
receptor for HB-EGF, that is, EGF receptor, is localized, 
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 Figure 8.  Localization  of  proHB-EGF,  DTR,  and 
EGF-R in Vero cells and Vero-H cells. Vero cells (A, 
B, and E) and Vero-H cells (C and D) were stained 
with anti-HB-EGF antibody (.4 and C), anti-EGF re- 
ceptor antibody (E), or DT (B and D) as described in 
Materials  and Methods. Bar, 50 p~m. 
we stained Vero cells with anti-EGF receptor antibody. It 
was also predominantly localized at cell--cell contact sites 
at least when cells were confluent  (Fig.  8  E),  indicating 
that membrane anchored HB-EGF can interact with EGF 
receptor of adjacent cells. 
Double staining of Vero-H cells with DT and anti-inte- 
grin et3 mAb is shown in Fig. 9. The patterns are quite sim- 
ilar for proHB-EGF and integrin et3. Although staining of 
intercellular process-like structures is more prominent in 
Vero-H ceils than Vero ceils when focus was adjusted at 
the  basement  membrane, the  patterns  stained  with  DT 
and anti-or3  mAb overlapped well (Fig. 9, A  and B). Cell- 
cell borders stained with anti-or3  as a continuous line (Fig. 
9  C) were also stained with DT (Fig. 9 D). As discussed 
above, DT preferentially labels proHB-EGF complexed 
with DRAP27/CD9. Thus, we conclude that proHB-EGF, 
DRAP27/CD9,  and integrin ot3lM are colocalized at cell- 
cell contact sites. 
Colocalization  of  proHB-EGF, DRAP271CD9, and 
Integrin  a3 with a-Catenin and Vinculin 
To investigate the significance of the association and colo- 
calization  of  proHB-EGF,  DRAP27/CD9,  and  integrin 
The Journal of Cell Biology,  Volume 129, 1995  1700 Figure 9.  Colocalization of integfin ct3131 and proHB-EGF stained with DT. Vero-H cells were double stained with DT and anti-inte- 
grin ct3 antibody and observed under a fluorescence microscope. A and C show integrin a3 and B and D show proHB-EGF stained with 
DT. Focus was adjusted at basement membrane (-4 and B), or lateral cell-cell contact sites (C and D). Bar, 50 p.m. 
ct3131, we  compared  the  location of these  proteins  with 
other proteins known to be involved in cell--cell and cell- 
substratum adhesions. Fig. 10 shows images from double 
staining for DRAP27/CD9 and either vinculin or ct-cate- 
nin.  Vinculin  is  known  to  be  localized at  actin-concen- 
trated focal contact sites, termed focal plaque and adher- 
ence junction in epithelial cells (Geiger, 1979; Volberg et 
al., 1986). At the basement membrane (z = 1), vinculin was 
concentrated  at  focal plaques,  which  is  a  pattern  quite 
different  from  that  of  DRAP27/CD9  (Fig.  10,  A-C). 
However,  at  the  position  z  =  2,  vinculin  was  localized 
mainly at cell--cell boundaries,  where  it largely overlaps 
with DRAP27/CD9  (Fig.  10, D-F). et-Catenin associates 
with cytoplasmic tail of cadherins and is localized at adher- 
ence junctions  (Takeichi,  1991;  Ozawa  et  al.,  1989).  In 
Vero ceils, et-catenin was mainly observed at positions z = 
2  to z  =  4, and its pattern overlapped that of DRAP27/ 
CD9, as shown in Fig. 10, G-I. Similar colocalization was 
observed with integrin a3 and et-catenin (data not shown). 
Although  we have not directly shown the colocalization 
of proHB-EGF with either ct-catenin or vinculin, proHB- 
EGF was colocalized with integrin et3 and DRAP27/CD9 
as  shown  in  Fig.  9.  These  results  indicate  that  proHB- 
EGF, DRAP27/CD9,  and integrin ct3131 are localized at 
cell--cell contact sites where oc-catenin and vinculin are lo- 
calized. Although it is not clear whether Vero cells form 
typical junctional structures, results suggest that proHB- 
EGF, DRAP27/CD9, and integfin a3131 colocalize at cell- 
cell contact sites  around adherence junctions. These re- 
suits support the idea that the proHB-EGF complex, in- 
cluding CD9 and integrin a3131, interacts with EGF recep- 
tors of adjacent cells at cell--cell contact sites. 
Discussion 
From the coprecipitation, cross-linking, and immunofluo- 
rescence  results  described  here,  we  conclude  that  (a) 
DRAP27/CD9 associates with integrin oL3131 in Vero cells 
and other human cell lines; (b) proHB-EGF associates with 
DRAP27/CD9 and integrin a3[M in Vero-H cells; and (c) all 
of these proteins, that is, proHB-EGF, DRAF27/CD9, and 
integrin a3[M, are localized at cell-cell contact sites.  How- 
ever, the number of proHB-EGF molecules on the surface 
of Vero cells is much lower than the number of DRAP27/ 
CD9 molecules, while the amount of integrin o~3131 appears 
to  be  similar  to  or  greater  than  that  of DRAP27/CD9. 
While a  large fraction of ~3131 associates with DRAP27/ 
CD9,  much smaller fractions of ~3[M  and DRAP27/CD9 
are likely to be associated with proHB-EGF in Vero cells. 
In  Vero-H  cells,  which  express  at  least  20  times  more 
proHB-EGF molecules on  the  cell  surface,  some  of the 
proHB-EGF molecules on the cell surface are apparently 
Nakamura et al. Association of  HB-EGF, DRAP27/CD9 and Integrin  1701 not associated with DRAP27/CD9 and ot3131. Staining with 
anti-HB-EGF  antibody  revealed  that  proHB-EGF  is 
present all around the cell surface in Vero-H cells, while 
DRAP27/CD9 and integrin ct3131 were localized mainly at 
cell--cell boundaries. Since proHB-EGF is localized at cell- 
cell contact sites in Vero cells, the broader distribution of 
proHB-EGF seen in Vero-H cells may be due to the over- 
expression of this protein. However, it is also possible that 
some of the proHB-EGF molecules in Vero cells also have 
a more dispersed distribution, but the amount is below the 
limit of detection. 
Does DRAP27/CD9 mediate the association of proHB- 
EGF with integrin ct3131? These studies do not rule out 
the possibility that other factors are  responsible for the 
association of proHB-EGF and 131 integrin. For example, 
proHB-EGF possibly binds heparan sulfate proteoglycans 
with its heparin-binding domain. Fibronectin is known to 
bind heparan sulphate proteoglycan and possibly integrin 
c~3131 by different domains (Ruoslahti, 1988).  Therefore, 
fibronectin or  fibronectin-like molecules may indirectly 
cross-link proHB-EGF and ot3131. However, immunopre- 
cipitation experiments showed that integrin ct3131 is copre- 
cipitated much more efficiently by anti-DRAP27 antibody 
than by anti-HB-EGF, so the simplest explanation is that 
association of proHB-EGF with integrin a3131 is mediated 
by DRAP27/CD9. 
Significance  of the Association of Integrin  od  fll 
with DRAP27/CD9 
The existence of membrane proteins that associate with 
integrins has been suggested because the cytoplasmic do- 
mains of most integrins may be too short to transduce out- 
side adhesion signals to the inside of cells (Juliano and 
Haskill, 1993).  However, until now only one membrane 
protein had been characterized as an integrin-associating 
protein. IAP, a 50-kD membrane protein with five mem- 
brane-spanning domains and an immunoglobulin-like do- 
main, is known to associate with leukocyte response inte- 
grin and integrin etv133 (Brown et al., 1990; Lindberg et al., 
1993). We demonstrated here that DRAP27/CD9 associ- 
ates with integrin a3131, the first example of a 131 integrin- 
associated membrane protein. 
An explanation of the biological significance of the asso- 
ciation of DRAP27/CD9  and integrin a3131 should take 
into account the observation that DRAP27/CD9 and inte- 
grin  a3131 colocalize  at  cell--cell  contact  sites.  Integrin 
ct3131 possibly functions as a receptor for a variety of ECM 
proteins including collagen, laminin, fibronectin (Takada 
et al., 1991), and the newly identified ECM proteins epili- 
grin (Carter et al., 1991)  and kalinin (Rousselle and Au- 
mailley,  1994).  A  feature  that  distinguishes ct3131 from 
other 131-containing integrins is that it is localized at cell- 
cell contact sites in epithelial cells (Carter  et al.,  1990). 
There have been a number of reports of the involvement 
of [31 integrin in intercellular adhesion. For example, anti- 
or3  and  anti-131 antibodies  inhibit intercellular adhesion 
and disrupt cell-cell contact (Carter et al., 1990; Larjava et 
al., 1990). Another anti-or3 mAb, P1B5, stimulated inter- 
cellular adhesion  of a  human  keratinocyte-derived cell 
line and also induced temperature-dependent homotypic 
cell aggregation of oL3-transfected cell lines (Symington et 
al., 1993; Weitzman et al., 1993). Homotypic interaction of 
integrin ct3131 (Sriramarao et al., 1993) and interaction of 
ot3131 with ot2131 (Symington et al., 1993) suggest that a3131 
might mediate intercellular adhesion. Thus we suggest that 
CD9, by its association with 0t3131, is implicated in cell-cell 
interaction. 
Interestingly, a3131 expression  has  been  shown to  in- 
crease on oncogenic transformation, suggesting that o~3131 
may contribute to tumorigenicity or metastatic cell motil- 
ity. Analysis of clinical specimens showed that expression 
levels of integrin a3131 are related to invasiveness of malig- 
nant melanoma (Natali et al., 1993). CD9 is also linked to 
tumorigenicity and cell motility; motility-related protein 
(MRP-1) is identical to CD9 (Miyake et al., 1991). Anti- 
MRP-1 mAb inhibited cell motility of several cancer cell 
lines.  Other  studies showed that  CD9  expression  is in- 
versely related to metastatic potential of melanoma (Si 
and Hersey, 1993), and transfection of CD9 eDNA causes 
suppression of cell motility and metastasis of cancer cell 
lines (Ikeyama et al., 1993). Thus, both integrin ct3131 and 
CD9 are implicated in cell motility and metastasis of tu- 
mor cells. We suggest that CD9 and ot3131 are included in 
an effector complex that is involved in intercellular adhe- 
sion and cell motility, and that CD9 may stimulate or sup- 
press the function of integrin ct3131. 
Although  we  could  not  detect  the  association  of 
DRAP27/CD9 with integrins other than ot3131 in Vero cell 
and A431 cell lysates, slight coprecipitation of o~2 and ct5 
was  observed  from MG63  cell lysates. Previous reports 
also suggested interaction of CD9 and other kinds of inte- 
grins: (a) incubation of platelets with anti-CD9 antibodies 
induces  the  association  of  CD9  with  platelet  integrin 
gplIb/IIIa (Slupsky et al., 1989);  (b)  anti-CD9 antibody 
and anti-integrin a4 antibody induce homotypic cellular 
aggregation by similar effector mechanisms in acute lym- 
phocytic leukemia cell lines not expressing the or3 subunit 
(Letarte et al., 1993); and (c) anti-CD9 antibody promotes 
the integrin-mediated adhesion of pre-B Cell to bone mar- 
row stroma cells (Masellis-Smith and Shaw, 1994). There- 
fore, CD9 may interact with other types of integrins in 
other systems. 
Significance  of the Association of lntegrin a3~l 
with proHB-EGF-DRAP271CD9 Complex 
Membrane-anchored growth factors can exert mitogenic 
activity by two modes:  the paracrine  mode, in which a 
cleaved soluble form is released, and the juxtacrine mode, 
in  which  the  membrane-anchored  form is  active  (Mas- 
sagu6 and Pandiella, 1993). The latter can provide mito- 
Figure 10. Colocalization  of DRAP27/CD9 with vinculin or ct-catenin. Fixed Vero cells were double stained with anti-CD9 mAb BU16 
(IgG2a) and anti-vinculin  mAb (IgG1) or rat anti-a-catenin, followed by FITC-labeled goat anti-mouse IgG2a and biotinylated goat anti- 
mouse IgG1 or goat anti-rat IgG and streptavidin-Cy3.  Fluorescent  images  for DRAP27/CD9 (A, D, and G), vinculin  (B and E) and a-catenin 
(H) were obtained using a confocal  microscope. Overlapping  areas between A and B, D and E, or G and H are shown  in yellow  in C, F, and/, 
respectively.  Focus was adjusted at the basement membrane (A-C), or at 1.2 pan above the basement membrane (D-/). Bar, 50 pan. 
Nakamura  et al. Association of  HB-EGF,  DRAP27/CD9  and lntegrin  1703 genic stimulation specifically to cells in direct contact even 
if  other  nearby  cells  are  expressing  the  same  receptor 
molecules.  We  have  recently  shown  that  membrane- 
anchored  HB-EGF  stimulates  cell  growth  in juxtacrine 
manner  to  acceptor  cells  expressing  EGF  receptor,  and 
that DRAP27/CD9  greatly upregulates the juxtacrine mi- 
togenic activity of proHB-EGF (Higashiyama et al., 1995). 
DRAP27 has no stimulatory effect on the mitogenic activ- 
ity  of  soluble  HB-EGF,  indicating  that  DRAP27/CD9 
must play a role in the regulation of juxtacrine activity of 
membrane-anchored  HB-EGF.  However,  the  acceptor 
cells used for the experiments were  suspension cells, not 
adherent cells; thus, the conditions in which the juxtacrine 
mitogenic activity was assayed might be somewhat artifi- 
cial. In this study we showed that proHB-EGF, DRAP27/ 
CD9, and integrin et3131 are localized at cell-cell  contact 
sites near adherence junctions. The EGF receptor is also 
known to be localized around adherence junctions (Fuku- 
yama and Shimizu, 1991), and we confirmed the localiza- 
tion of EGF  receptors  at the cell--cell boundary in Vero 
cells. Thus, all components of the juxtacrine signal mecha- 
nism are located in the same region, suggesting that mem- 
brane-anchored HB-EGF  on one adherent cell and EGF 
receptor on a neighboring adherent cell can interact. 
While it is not certain whether et3[31-associated  proHB- 
EGF-DRAP27/CD9  complex is mitogenically active, sev- 
eral possible roles for the complex can be considered: (a) 
et3131 may sustain the interaction of proHB-EGF-DRAP27/ 
CD9  complex  with  EGF  receptor.  Since  membrane- 
anchored growth factors require direct contact with the re- 
ceptors to transmit a signal, the involvement of cell adhe- 
sion molecules  in  this  process  would  be  reasonable.  (b) 
DRAP27/CD9 forms a complex with proHB-EGF and up- 
regulates  its  juxtacrine  mitogenic  activity.  Integrin  ec3131 
may regulate the mitogenic activity of proHB-EGF through 
its interaction with DRAP27/CD9, rather than as an adhe- 
sion molecule. In this context it should be noted that colo- 
calization  of  proHB-EGF,  DRAP27/CD9,  and  integrin 
a3131 at cell--cell boundaries was observed in confluent cell 
cultures, in which cell growth of Vero ceils and Vero-H cells 
has ceased or slowed greatly compared with the semiconflu- 
ent stage. Therefore, a3131 may suppress the mitogenic ac- 
tivity of membrane-anchored HB-EGF rather than stimu- 
late it. 
We  should also  consider that proHB-EGF,  DRAP27/ 
CD9, and integrin a3131 are colocalized with oc-catenin and 
vinculin at cell-cell  contact sites,  e~-Catenin and vinculin 
are known to be localized at adherence junctions, one of 
the junctional structures  where  cadherin  plays  a  central 
role in cell-cell adhesion (Takeichi, 1991). A recent report 
showed that activation of the E-cadherin system  in PC9 
lung carcinoma cells retarded cell growth, suggesting that 
the cadherin system is involved in regulation of cell prolif- 
eration as well  (Watabe  et al., 1994).  Although it is  not 
clear whether Vero cells form typical junctional structures, 
our results indicate that proHB-EGF, DRAP27/CD9,  and 
integrin a3131 are colocalized with adherence junction pro- 
teins.  It  appears  that cell  adhesion  molecules  and some 
growth control factors are concentrated around adherence 
junctions, and these molecules  form a network that con- 
trois cell proliferation and cell motility in a cell adhesion- 
dependent  process  (Tsukita  et  al.,  1991;  Behrens  et  al., 
1993;  Hamaguchi  et  al.,  1993).  This  process  would  be 
dynamically controlled  by  the  adhesion  molecules  and 
growth factors. Our results indicate the possibility of direct 
cooperation  of membrane-anchored  growth factors  and 
adhesion molecules in cell--cell interactions between adja- 
cent cells, and that DRAP27/CD9 may play a role in this 
cooperation. 
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